According to filings with the U.S. Securities and Exchange Commission, Micro Medical Solutions is raising up to $16,416,000.00 in new funding. The federal securities law requires the notice to be filed by companies that have sold securities without registration under the Securities Act of 1933 in an offering made under Rule 504 or 506 of Regulation D or Section 4(a)(5) of the Securities Act. A company must file this notice within 15 days after the first sale of securities in the offering. For this purpose, the date of first sale is the date on which the first investor is irrevocably contractually committed to invest. Each issuer of securities that sells its securities in reliance on an exemption provided in Regulation D or Section 4(a)(5) of the Securities Act of 1933 must file this notice containing the information requested with the U.S. Securities and Exchange Commission (SEC) and with the state(s) requiring it. If more than one issuer has sold its securities in the same transaction, all issuers should be identified in this filing with the SEC.

About Micro Medical Solutions
Micro Medical Solutions (MMS) is a company dedicated to developing innovative microvascular intervention technologies to address the critical unmet needs of patients suffering from peripheral artery disease (PAD) and critical limb ischemia (CLI). The company’s primary mission is to significantly reduce amputation rates, improve clinical outcomes, and enhance the quality of life for these patients, while also minimizing the associated financial and human costs. MMS provides physicians with minimally invasive tools and technology to combat the impact of CLI, focusing on solutions for below-the-knee interventions. Their flagship product, the MicroStent, is a vascular stent specifically designed to manage below-the-knee arterial disease and prevent amputations. Micro Medical Solutions is actively engaged in clinical studies, including the FDA randomized, multicenter pivotal clinical study STAND, and the HEAL observational study in the EU, to further validate their technology.

To learn more about Micro Medical Solutions, visit https://micromedicalsolutions.net/
Micro Medical Solutions Linkedin Page: https://www.linkedin.com/search/results/companies/?keywords=Micro%20Medical%20Solutions

Contact:
George Quinoy, President and Chief Executive Officer
877-760-0677

SOURCE: http://www.intelligence360.io
Copyright (c) 2025 SI360 Inc. All rights reserved.